Bank of New York Mellon Corp cut its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 1.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 182,715 shares of the medical instruments supplier’s stock after selling 2,433 shares during the quarter. Bank of New York Mellon Corp owned about 0.91% of ICU Medical worth $33,957,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of ICU Medical by 10.3% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 707 shares of the medical instruments supplier’s stock worth $122,000 after purchasing an additional 66 shares during the period. Riverhead Capital Management LLC grew its holdings in shares of ICU Medical by 99.8% during the 2nd quarter. Riverhead Capital Management LLC now owns 999 shares of the medical instruments supplier’s stock worth $172,000 after purchasing an additional 499 shares during the period. Victory Capital Management Inc. grew its holdings in shares of ICU Medical by 17.6% during the 2nd quarter. Victory Capital Management Inc. now owns 1,050 shares of the medical instruments supplier’s stock worth $181,000 after purchasing an additional 157 shares during the period. Teacher Retirement System of Texas purchased a new position in ICU Medical during the 2nd quarter valued at about $214,000. Finally, Ameritas Investment Partners Inc. boosted its holdings in ICU Medical by 4.0% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 1,321 shares of the medical instruments supplier’s stock valued at $228,000 after acquiring an additional 51 shares during the period. Institutional investors and hedge funds own 78.15% of the company’s stock.
ICU Medical, Inc. (NASDAQ ICUI) opened at $210.80 on Friday. ICU Medical, Inc. has a twelve month low of $127.00 and a twelve month high of $218.45. The company has a market capitalization of $4,165.01, a PE ratio of 81.14, a P/E/G ratio of 3.32 and a beta of 0.36. The company has a current ratio of 4.65, a quick ratio of 3.01 and a debt-to-equity ratio of 0.07.
A number of brokerages recently commented on ICUI. BidaskClub cut ICU Medical from a “hold” rating to a “sell” rating in a report on Thursday, August 24th. Zacks Investment Research upgraded ICU Medical from a “sell” rating to a “hold” rating in a report on Wednesday, October 11th. Gabelli restated a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. Finally, KeyCorp began coverage on ICU Medical in a report on Tuesday, October 17th. They set a “sector weight” rating for the company. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $232.00.
In other news, Director Robert S. Swinney sold 463 shares of ICU Medical stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $181.25, for a total value of $83,918.75. Following the completion of the transaction, the director now owns 14,330 shares in the company, valued at approximately $2,597,312.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Joseph R. Saucedo sold 2,000 shares of ICU Medical stock in a transaction dated Tuesday, November 21st. The shares were sold at an average price of $216.06, for a total value of $432,120.00. Following the completion of the transaction, the director now owns 554,364 shares of the company’s stock, valued at approximately $119,775,885.84. The disclosure for this sale can be found here. Insiders have sold a total of 119,663 shares of company stock valued at $22,887,437 over the last 90 days. 13.60% of the stock is currently owned by company insiders.
TRADEMARK VIOLATION WARNING: This report was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://sportsperspectives.com/2017/12/09/icu-medical-inc-icui-shares-sold-by-bank-of-new-york-mellon-corp.html.
About ICU Medical
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.